•
SUZHOU—Roche Diagnostics, the Swiss healthcare giant, has entered into a new investment agreement with the Suzhou Industrial Park, marking a significant expansion of its presence in China. The company will invest RMB 3 billion in a new project for its Suzhou plant, which is anticipated to be operational by 2028.…
•
Roche Diagnostics (SWX: ROG), the Swiss diagnostics heavyweight, has furthered its collaboration with Beijing Strong Biotechnologies Inc. (SHE: 300406), a Chinese partner, to craft more holistic and pioneering laboratory solutions for hemostasis and thrombotic disorders. Building on their initial partnership established in 2016, which focused on biochemical reagents and resulted…